Enliven Therapeutics, Inc. |
10%+ Owner |
Common Stock |
3.2M |
$47.7M |
$14.90 |
Feb 14, 2024 |
By 5AMVentures VI, L.P. |
Enliven Therapeutics, Inc. |
10%+ Owner |
Common Stock |
635K |
$9.47M |
$14.90 |
Feb 14, 2024 |
By 5AM Opportunities I, L.P. |
Camp4 Therapeutics Corp |
10%+ Owner |
Common Stock |
2.63M |
|
|
Oct 15, 2024 |
By 5AM Ventures VI, L.P. |
Artiva Biotherapeutics, Inc. |
10%+ Owner |
Common Stock |
1.18M |
|
|
Jul 22, 2024 |
By 5AM Opportunities II, L.P. |
Artiva Biotherapeutics, Inc. |
10%+ Owner |
Common Stock |
1.17M |
|
|
Jul 22, 2024 |
By 5AM Ventures VI, L.P. |
Camp4 Therapeutics Corp |
10%+ Owner |
Common Stock |
303K |
|
|
Oct 15, 2024 |
By 5AM Opportunities II, L.P. |
Artiva Biotherapeutics, Inc. |
10%+ Owner |
Series A Preferred Stock |
0 |
|
|
Jul 22, 2024 |
By 5AM Ventures VI, L.P. |
Artiva Biotherapeutics, Inc. |
10%+ Owner |
Series B Preferred Stock |
0 |
|
|
Jul 22, 2024 |
By 5AM Ventures VI, L.P. |
Camp4 Therapeutics Corp |
10%+ Owner |
Series A Prime Preferred Stock |
0 |
|
|
Oct 15, 2024 |
By 5AM Ventures VI, L.P. |
Camp4 Therapeutics Corp |
10%+ Owner |
Series B Preferred Stock |
0 |
|
|
Oct 15, 2024 |
By 5AM Opportunities II, L.P. |
Camp4 Therapeutics Corp |
10%+ Owner |
Series B Preferred Stock |
0 |
|
|
Oct 15, 2024 |
By 5AM Ventures VI, L.P. |
CinCor Pharma, Inc. |
10%+ Owner |
Common Stock |
0 |
|
$28.75 |
Feb 24, 2023 |
By 5AM Opportunities II, L.P. |
CinCor Pharma, Inc. |
10%+ Owner |
Common Stock |
0 |
|
$28.75 |
Feb 24, 2023 |
By 5AM Opportunities I, L.P. |
CinCor Pharma, Inc. |
10%+ Owner |
Common Stock |
0 |
|
$28.75 |
Feb 24, 2023 |
By 5AM Ventures VI, L.P. |